140 related articles for article (PubMed ID: 30734613)
1. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.
Zhang L; Chen Q; Hou G; Zhao W; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):264-271. PubMed ID: 30734613
[TBL] [Abstract][Full Text] [Related]
2. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
Li N; Xin WY; Yao BR; Wang CH; Cong W; Zhao F; Li HJ; Hou Y; Meng QG; Hou GG
Eur J Med Chem; 2018 Mar; 147():21-33. PubMed ID: 29421568
[TBL] [Abstract][Full Text] [Related]
3. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.
Yao BR; Sun Y; Chen SL; Suo HD; Zhang YL; Wei H; Wang CH; Zhao F; Cong W; Xin WY; Hou GG
Eur J Med Chem; 2019 Apr; 167():187-199. PubMed ID: 30771605
[TBL] [Abstract][Full Text] [Related]
4. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
Cong W; Sun Y; Sun YF; Yan WB; Zhang YL; Gao ZF; Wang CH; Hou GG; Zhang JJ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1622-1631. PubMed ID: 34284695
[TBL] [Abstract][Full Text] [Related]
5. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
[TBL] [Abstract][Full Text] [Related]
9. "Half-sandwich" Schiff-base Ir(III) complexes as anticancer agents.
Mou ZD; Deng N; Zhang F; Zhang J; Cen J; Zhang X
Eur J Med Chem; 2017 Sep; 138():72-82. PubMed ID: 28646657
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence.
Sun J; Wang S; Li H; Jiang W; Hou G; Zhao F; Cong W
J Enzyme Inhib Med Chem; 2016; 31(3):495-502. PubMed ID: 26382011
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties.
Sun J; Zhang S; Yu C; Hou G; Zhang X; Li K; Zhao F
Chem Biol Drug Des; 2014 Apr; 83(4):392-400. PubMed ID: 24148151
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity.
Kálai T; Kuppusamy ML; Balog M; Selvendiran K; Rivera BK; Kuppusamy P; Hideg K
J Med Chem; 2011 Aug; 54(15):5414-21. PubMed ID: 21702507
[TBL] [Abstract][Full Text] [Related]
14. Conjugates of 3,5-Bis(arylidene)-4-piperidone and Sesquiterpene Lactones Have an Antitumor Effect via Resetting the Metabolic Phenotype of Cancer Cells.
Neganova ME; Aleksandrova YR; Sharova EV; Smirnova EV; Artyushin OI; Nikolaeva NS; Semakov AV; Schagina IA; Akylbekov N; Kurmanbayev R; Orynbekov D; Brel VK
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930831
[TBL] [Abstract][Full Text] [Related]
15. Halogenated Bis(methoxybenzylidene)-4-piperidone Curcuminoids with Improved Anticancer Activity.
Schmitt F; Subramaniam D; Anant S; Padhye S; Begemann G; Schobert R; Biersack B
ChemMedChem; 2018 Jun; 13(11):1115-1123. PubMed ID: 29570947
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
Cao D; Wang X; Lei L; Ma L; Wang F; Wang C; Tang M; Xiang W; Wang T; Li H; Chen L
Bioorg Med Chem Lett; 2016 Apr; 26(8):1931-5. PubMed ID: 26979159
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
[TBL] [Abstract][Full Text] [Related]
19. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents.
Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS
Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives.
Rafiq M; Nazir Y; Ashraf Z; Rafique H; Afzal S; Mumtaz A; Hassan M; Ali A; Afzal K; Yousuf MR; Saleem M; Kotwica-Mojzych K; Mojzych M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-11. PubMed ID: 31456445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
